Department of Orthopedics and Traumatology, Sakarya Research and Training Hospital, Sakarya, Turkey.
Department of Orthopedics and Traumatology, Bezmialem Vakif University, Istanbul, Turkey.
Med Sci Monit. 2018 Feb 25;24:1166-1170. doi: 10.12659/msm.908560.
BACKGROUND Adequate visualization is known to be essential to perform arthroscopic procedures effectively and efficiently. We hypothesized that tranexamic acid may be considered as an alternative agent to reduce intra-articular bleeding during arthroscopic procedures, after comparing its potential chondrotoxicity with that of epinephrine. MATERIAL AND METHODS Seventy-two rats were randomized into 3 groups with 24 rats each. The injections were performed in the right knees, as follows: Group 1: 0.25 mL of tranexamic acid solution, Group 2: 0.25 mL of epinephrine solution, and Group 3: 0.25 mL of 0.9% saline, serving as control. One week after the injections, the animals were euthanized. Samples were evaluated histologically based on the Osteoarthritis Research Society International (OARSI) Histopathology Grading and Staging System and the "live/dead" staining technique to determine chondrocyte viability. RESULTS Comparison of epinephrine and tranexamic acid revealed significantly higher OARSI scores in the epinephrine group (epinephrine: 3.42±1.31, TA: 0.92±0.90; P<0.001). The most significant difference between the 2 groups was in the number of joints diagnosed with OARSI grade III. The percentage of viability was significantly higher in the tranexamic acid group when compared with the epinephrine group (tranexamic acid: 79.74±3.343; epinephrine: 63.81±1.914; P<0.05). CONCLUSIONS Based on the histologic parameters and chondrocyte viability, tranexamic acid is less cytotoxic than epinephrine in rat chondrocytes at the doses typically used in irrigation fluid, and may be a good alternative to epinephrine in arthroscopic surgery.
充分的可视化被认为是有效和高效地进行关节镜手术的必要条件。我们假设,在比较氨甲环酸的潜在软骨毒性与肾上腺素的软骨毒性之后,氨甲环酸可以被视为关节镜手术中减少关节内出血的替代药物。
72 只大鼠随机分为 3 组,每组 24 只。注射部位为右膝关节,具体分组如下:第 1 组:氨甲环酸溶液 0.25 mL;第 2 组:肾上腺素溶液 0.25 mL;第 3 组:0.9%生理盐水 0.25 mL,作为对照。注射后 1 周,处死动物。根据骨关节炎研究协会国际(OARSI)组织病理学分级和分期系统以及“活/死”染色技术对标本进行组织学评估,以确定软骨细胞活力。
与肾上腺素相比,氨甲环酸组的 OARSI 评分显著更高(肾上腺素:3.42±1.31,TA:0.92±0.90;P<0.001)。两组之间最显著的差异在于诊断为 OARSI Ⅲ级的关节数量。与肾上腺素组相比,氨甲环酸组的活力百分比显著更高(氨甲环酸:79.74±3.343;肾上腺素:63.81±1.914;P<0.05)。
根据组织学参数和软骨细胞活力,氨甲环酸在关节镜手术中常用的灌洗液剂量下,其细胞毒性小于肾上腺素,可能是肾上腺素在关节镜手术中的良好替代品。